Smartlab Europe

Press Releases

Analytica Anacon India and India Lab Expo 2016

The ninth annual edition of analytica Anacon India and India Lab Expo, India’s leading trade fairs for the laboratory technology, analysis, biotechnology and diagnostics market, take place from October 20 to 22, 2016 at the HITEX Exhibition Centre in...

Roche says first phase III data on tecentriq to feature at the ESMO Congress

Roche announced that new results from studies with its approved or investigational medicines across more than 20 cancer types will be presented during the European Society for Medical Oncology (ESMO) Congress from 7 – 11 October 2016 in Copenhagen,...

Videojet launches new 100-Watt fiber laser marking system to address manufacturers’ need for power and speed 

To meet manufacturers’ demands for high-speed applications such as bottle cap printing and pull tab engraving, Videojet Technologies, a global leader in coding, marking and printing solutions, has introduced a 100-Watt fiber laser the Videojet 7610 (www.videojet.com/7610) to complete...

Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer Healthcare

Sanofi announced the appointment of Alan Main as Executive Vice President Consumer HealthCare, effective October 1st, 2016. Mr. Main will be a member of the Executive Committee and lead a newly created Consumer Healthcare global business unit. ...

GlaxoSmithKline plc appoints Brian McNamara as CEO of GSK Consumer Healthcare

  GSK announced that Brian McNamara, is appointed Chief Executive Officer (CEO) of GSK’s Consumer Healthcare division effective immediately.   He succeeds Emma Walmsley who was last week appointed GSK CEO Designate succeeding Sir Andrew Witty...

Teva Announces Launch of Generic Epzicom® Tablets in the United States

Teva Pharmaceutical Industries Ltd announced the launch of a generic equivalent of Epzicom®1 (abacavir and lamivudine) tablets, 600 mg/300 mg, in the United States (U.S.). Abacavir and lamivudine tablets are indicated in combination with other antiretroviral agents for the...

Gilead Sciences and the World Health Organization Announce Five-Year Visceral Leishmaniasis Collaboration

Gilead Sciences Inc announced it has entered into a partnership with the World Health Organization (WHO) to provide $20 million in funding and drug donations over five years to expand access to diagnostic services and treatment for visceral leishmaniasis...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »